HASTINGS DAVID C

Average Profitability
18.13%
Insider Buys Quantity
5
Insider Buys Sum
$113,918.92
Insider Sells Quantity
9
Insider Sells Sum
$36.23M

Insider Activity of HASTINGS DAVID C

According to the SEC Form 4 filings, HASTINGS DAVID C, being in a position of

  1. Chief Financial Officer at Arbutus Biopharma Corporation,
    оver the last 12 months, has bought 0 shares, and sold 9593 shares for $22,184,
    over all time since 2024-02-02, has bought 0 shares, and sold 9593 shares for $22,184.

The largest purchase of all time was on 2018-03-08 and amounted to 23668 shares of SCYNEXIS, Inc. for $39,999.

The largest sale of all time was on 2014-02-13 and amounted to 202999 shares of Incyte Corporation for $13.42M.

Biography of HASTINGS DAVID C

No biography is available at this moment.

2024-02-02SaleArbutus Biopharma Corporation
ABUS
Chief Financial Officer
9,593
0.0054%
$2.31$22,184+40.34%
2018-03-08PurchaseSCYNEXIS, Inc.
SCYX
director
23,668
0.0857%
$1.69$39,999-8.63%
2017-06-21PurchaseSCYNEXIS, Inc.
SCYX
director
20,000
0.0757%
$1.75$35,000+1.68%
2014-06-05SaleIncyte Corporation
INCY
Chief Financial Officer
123,966
0.0736%
$52.81$6.55M+37.71%
2014-06-04SaleIncyte Corporation
INCY
Chief Financial Officer
76,034
0.0454%
$52.61$4M+38.28%
2014-02-18SaleIncyte Corporation
INCY
Chief Financial Officer
32,001
0.0194%
$65.64$2.1M-17.28%
2014-02-14SaleIncyte Corporation
INCY
Chief Financial Officer
40,000
0.0244%
$64.74$2.59M-15.6%
2014-02-13SaleIncyte Corporation
INCY
Chief Financial Officer
202,999
0.1227%
$66.12$13.42M-18.08%
2013-09-06SaleIncyte Corporation
INCY
Chief Financial Officer
100,000
0.0637%
$35.16$3.52M+40.9%
2013-02-15SaleIncyte Corporation
INCY
Chief Financial Officer
100,000
0.0762%
$22.52$2.25M+24.05%
2011-06-09SaleIncyte Corporation
INCY
Chief Financial Officer
100,000
0.078%
$17.76$1.78M-6.64%
2010-07-01PurchaseIncyte Corporation
INCY
Chief Financial Officer
2,000
0.0016%
$10.24$20,480+47.44%
2008-11-20PurchaseIncyte Corporation
INCY
Chief Financial Officer
4,000
0.0042%
$2.36$9,440+38.15%
2006-04-04PurchaseIncyte Corporation
INCY
Chief Financial Officer
2,500
0.003%
$3.60$9,000+33.61%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.